• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Immunohistochemically Detected Expression of Three Major Genes (CDKN2A/p16,TP53 and SMAD4/DPC4) Strongly Predicts Survival in Patients with Pancreatic Cancer

Research Project

Project/Area Number 24592029
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionKagawa University

Principal Investigator

OSHIMA Minoru  香川大学, 医学部附属病院, 助教 (60624830)

Co-Investigator(Kenkyū-buntansha) YACHIDA Shinichi  独立行政法人国立がん研究センター, 研究所がんゲノミクス研究分野, ユニット長 (20359920)
OKANO Keiichi  香川大学, 消化器外科, 准教授 (20314916)
SUZUKI Yasuyuki  香川大学, 消化器外科, 教授 (40304092)
Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2013: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2012: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords通常型膵管癌 / 遺伝子異常 / 膵臓癌 / 国際情報交換
Outline of Final Research Achievements

The pancreatic ductal adenocarcinoma (PDAC) contains 4 frequently mutated genes (KRAS, TP53, p16, SMAD4). We determined the status of TP53, p16, SMAD4 since the KRAS gene is mutated in virtually all PDAC patients, and analyzed relationships with clinicopathological findings in 106 surgical patients with PDAC .
Abnormal of p53 (81%) was associated with the presence of locoregional recurrence. Loss of p16 (67%) was associated with postoperative widespread metastases. Loss of Smad4 (60%) was associated with the tumor size and lymph node metastasis. Loss of Smad4 was an independent and significant poor prognostic factor for overall survival. On analysis of combinations of the status of these 3 genes, increasing number of alterations reflected poorer survival.
Genetic alterations of these 3 genes and their accumulation are strongly associated with malignant behavior of PDAC. Their assessment may provide a new prognostic tool, assisting in deciding optimal therapeutic strategies.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (3 results)

All 2013

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (1 results)

  • [Journal Article] Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer2013

    • Author(s)
      Minoru Oshima, Keiichi Okano, Shinobu Muraki, Reiji Haba, Takashi Maeba, Yasuyuki Maeba, Shinichi Yachida
    • Journal Title

      Annals of Surgery

      Volume: 258 Issue: 2 Pages: 336-346

    • DOI

      10.1097/sla.0b013e3182827a65

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer.2013

    • Author(s)
      Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S.
    • Journal Title

      Annals of Surgery

      Volume: 未掲載

    • Related Report
      2012 Research-status Report
    • Peer Reviewed
  • [Presentation] 通常型膵管癌における主要3遺伝子(p16,TP53,SMAD4)の変異は生物学的悪性度を強く規定する2013

    • Author(s)
      大島稔 谷内田真一 岡野圭一 前場隆志 鈴木康之
    • Organizer
      第113回 日本外科学会定期学術集会
    • Place of Presentation
      福岡国際会議場
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi